CDK6 and cancer: The miR-551b shows a negative correlation with CDK6 and SETD2 in cancer models.55,56 While direct evidence in osteoblasts is limited, miR-551b’s role in other tissues suggests it may target genes like RUNX2 or Osterix (key osteogenic transcription factors), which warrants further investigation.